AL
CTVA icon

Aspiriant LLC’s Corteva CTVA Stock Holding History

Aspiriant LLC’s Portfolio CTVA Stock Details CTVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240K Buy
2,830
+322
+13% +$25.9K 0.01% 355
2026
Q1 		$210K Buy
+2,508
New +$189K 0.01% 331

Other funds holding CTVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Aspiriant LLC's CTVA Position: Q2 2026 in Review

Aspiriant LLC increased its Corteva (CTVA) stake by 13% in Q2 2026, buying an estimated $25.9K and bringing the position to 2,830 shares worth $240K. The position accounts for 0.01% of the portfolio, ranked #355.

Aspiriant LLC first reported a position in CTVA in Q1 2026 and has held it in 2 quarters since. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Aspiriant LLC held 2,830 shares of Corteva worth $240K as of Q2 2026.
  • Aspiriant LLC bought 322 Corteva shares in Q2 2026, an estimated $25.9K.
  • Corteva made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #355 holding.
  • Aspiriant LLC first reported a position in Corteva in Q1 2026 and has held it in 2 quarters since.
  • 1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.